GlassScriptPhysician profile
Donald Edward Stephens
NPI 1205891215
$655.02
in general payments reported to CMS, 2019-2025
12 companies · $16.05 in 2025
The $16.05 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $545 · 2020: $35.06 · 2022: $58.61 · 2025: $16.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $125.47 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.16 | 2019-2020 | |
| Pfizer INC. | $81.61 | 2019-2022 | |
| Novo Nordisk INC | $76.40 | 2019 | |
| Amgen INC. | $67.23 | 2019 | |
| Janssen Pharmaceuticals, INC | $55.95 | 2019 | |
| Baxter Healthcare | $42.70 | 2022 | |
| Lilly USA, LLC | $29.78 | 2019 | |
| Gilead Sciences, INC. | $16.05 | 2025 | |
| Merck Sharp & Dohme LLC | $14.05 | 2019 | |
| Glaxosmithkline, LLC. | $13.52 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.10 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.